background
hypoalbuminemia
reliabl
predictor
mortal
patient
variou
ill
well
predictor
disabl
mortal
healthi
older
adult
associ
hypoalbuminemia
mortal
patient
idiopath
interstiti
pneumonia
remain
unknown
object
studi
examin
relationship
serum
albumin
concentr
mortal
larg
cohort
patient
idiopath
interstiti
pneumonia
list
lung
transplant
patient
classifi
idiopath
pulmonari
fibrosi
list
lung
transplant
unit
network
organ
share
januari
decemb
studi
relationship
serum
albumin
concentr
time
list
mortal
await
transplant
result
lower
serum
albumin
associ
increas
mortal
rate
patient
lower
categori
serum
albumin
increas
mortal
rate
multivari
adjust
p
valu
linear
trend
analysi
serum
albumin
continu
predictor
indic
mortal
rate
increas
gdl
decreas
serum
albumin
concentr
confid
interv
lower
serum
albumin
strongli
independ
associ
higher
transplantwait
list
mortal
patient
idiopath
interstiti
pneumonia
hypoalbuminemia
reliabl
predictor
mortal
patient
variou
ill
well
predictor
disabl
mortal
healthi
older
adult
prognost
valu
low
serum
albumin
may
reflect
ongo
inflamm
malnutrit
loss
albumin
protect
effect
vasodilat
inhibit
endotheli
cell
apoptosi
antioxid
effect
reduc
platelet
aggreg
role
inflamm
idiopath
pulmonari
fibrosi
ipf
remain
controversi
evid
inflamm
may
critic
condit
serum
albumin
neg
acut
phase
protein
therefor
readili
avail
marker
inflamm
acut
phase
respons
lead
releas
acut
phase
cytokin
includ
act
via
specif
hepat
receptor
inhibit
synthesi
albumin
addit
via
posit
autocrin
feedback
loop
promot
prolifer
lung
fibroblast
condit
malnutrion
liverkidney
diseas
may
also
affect
albumin
level
howev
associ
hypoalbuminemia
mortal
patient
idiopath
interstiti
pneumonia
iip
remain
unknown
studi
evalu
relationship
serum
albumin
concentr
mortal
larg
cohort
patient
iip
list
lung
transplant
hypothes
lower
serum
albumin
concentr
time
list
would
associ
higher
mortal
await
lung
transplant
analyz
data
organ
procur
transplant
network
optn
unit
network
organ
share
uno
databas
queri
individu
idiopath
pulmonari
fibrosi
ipf
list
lung
transplant
januari
decemb
diagnosi
ipf
standard
therefor
categori
like
includ
patient
iip
ucla
institut
review
board
approv
studi
patient
characterist
time
list
transplant
data
obtain
standard
transplant
analysi
research
star
file
base
organ
procur
transplant
network
optn
data
august
clinic
staff
transplant
center
unit
state
collect
demograph
clinic
data
time
list
date
list
transplant
andor
remov
list
obtain
star
file
death
august
determin
use
social
secur
death
master
file
star
dataset
primari
endpoint
mortal
list
lung
transplant
use
cox
proport
hazard
regress
analysi
examin
relationship
serum
albumin
time
list
transplant
waitinglist
mortal
rate
adjust
import
covari
surviv
time
comput
start
date
list
transplant
primari
analysi
experi
endpoint
transplant
removaldelist
death
transplant
censor
august
transplant
censor
date
transplant
remov
list
censor
date
delist
examin
natur
relationship
serum
albumin
concentr
mortal
whether
grade
threshold
relationship
categor
serum
albumin
concentr
quintil
regroup
three
middl
quintil
equispac
categori
result
five
categori
gdl
monoton
mortal
trend
found
across
five
categori
serum
albumin
conduct
cox
analys
serum
albumin
continu
predictor
model
adjust
variabl
influenc
surviv
patient
ipf
age
gender
race
forc
vital
capac
fvc
predict
flow
rate
supplement
oxygen
requir
rest
req
sixminut
walk
distanc
mean
pulmonari
arteri
pressur
mpap
determin
rightheart
catheter
rhc
lung
alloc
score
la
variabl
affect
serum
albumin
serum
creatinin
scr
bodi
mass
index
bmi
eversmok
statu
corticosteroid
use
diabet
mellitu
covari
ad
model
three
step
demograph
variabl
measur
pulmonari
statu
condit
marker
condit
affect
serum
albumin
level
bmi
marker
malnutrit
scr
marker
renal
dysfunctionproteinuria
corticosteroid
use
diabet
mellitu
eversmok
statu
covari
miss
data
imput
use
mean
mode
distribut
covari
includ
indic
variabl
flag
imput
valu
sensit
analys
reran
final
model
exclud
imput
valu
eversmok
statu
mpap
req
fvc
predict
corticosteroid
use
diabet
mellitu
ad
la
final
model
test
albumin
prognost
valu
independ
la
score
sinc
major
reason
remov
transplant
wait
list
worsen
health
conduct
sensit
analysi
everyon
remov
list
treat
hesh
die
date
remov
address
possibl
bia
censor
due
transplant
also
perform
sensit
analysi
assum
everyon
transplant
die
day
transplant
also
perform
sensit
analys
includ
posttranspl
surviv
includ
timevari
covari
perform
lung
transplant
supplementari
analys
examin
select
interact
term
age
albumin
gender
albumin
proport
hazard
assumpt
assess
use
loglog
plot
test
twotail
p
valu
requir
statist
signific
statist
analys
perform
use
sa
version
sa
institut
inc
cari
nc
medcalc
window
version
medcalc
softwar
mariakerk
belgium
patient
list
januari
decemb
exclud
serum
albumin
concentr
unavail
reduc
sampl
size
subject
shown
tabl
systemat
differ
studi
sampl
exclud
median
followup
period
day
rang
total
patient
die
transplant
remov
wait
list
underw
lung
transplant
associ
serum
albumin
concentr
probabl
lung
transplant
mean
serum
albumin
gdl
transplant
group
vs
gdl
transplant
group
p
although
serum
albumin
weakli
correl
la
use
priorit
iip
patient
transplant
r
ci
signific
differ
proport
patient
transplant
across
categori
serum
albumin
p
tabl
patient
lower
categori
serum
albumin
increas
mortal
rate
multivari
adjust
mortal
rate
increas
monoton
across
decreas
albumin
categori
tabl
figur
analysi
albumin
concentr
continu
predictor
gdl
decreas
serum
albumin
concentr
associ
mortal
hazard
ratio
hr
associ
weaken
slightli
multivari
adjust
adjust
hr
ci
p
result
similar
addit
adjust
la
hr
ci
p
sensit
analys
exclud
everyon
imput
valu
associ
similar
adjust
hr
ci
p
adjust
transplant
timedepend
covari
includ
posttranspl
surviv
result
remain
signific
per
gdl
decreas
hr
ci
p
addit
sensit
analys
anyon
remov
transplant
wait
list
receiv
transplant
assum
die
date
delist
associ
persist
adjust
hr
ci
furthermor
sensit
analysi
aim
address
possibl
bia
censor
due
transplant
assum
everyon
transplant
die
day
transplant
albuminmort
associ
remain
strong
signific
per
gdl
decreas
adjust
hr
ci
p
lastli
incorpor
cox
proport
hazard
regress
analysi
interact
term
signific
age
albumin
p
gender
albumin
low
serum
albumin
strongli
independ
associ
high
transplantwait
list
mortal
iip
surpris
find
studi
grade
relationship
albumin
mortal
character
mark
increas
mortal
rate
even
small
reduct
serum
albumin
concentr
increas
mortal
rate
gdl
decreas
serum
albumin
concentr
increas
gdl
decreas
gdl
gdl
hypoalbuminemia
power
predictor
mortal
patient
variou
ill
suggest
either
reduc
avail
albumin
underli
caus
hypoalbuminemia
reduc
surviv
albumin
number
essenti
physiolog
effect
necessari
normal
health
vasodilat
inhibit
endotheli
cell
apoptosi
antioxid
effect
reduc
platelet
aggreg
howev
simpli
administ
albumin
patient
hypoalbuminemia
shown
improv
surviv
reduc
morbid
suggest
underli
caus
hypoalbuminemia
rather
low
albumin
level
per
se
respons
increas
mortal
lead
caus
hypoalbuminemia
malnutrit
reduc
synthesi
liver
renal
loss
chronic
inflamm
hypolbuminemia
frequent
attribut
malnutrit
howev
albumin
level
remain
virtual
unchang
even
presenc
sever
protein
calori
malnutrit
near
termin
starvat
albumin
level
also
decreas
direct
result
protein
loss
bodi
nephrot
syndrom
consequ
reduc
synthesi
occur
liver
diseas
studi
includ
adjust
serum
creatinin
level
reduc
renal
function
explain
observ
albuminmort
associ
iip
observ
serum
albumin
neg
acut
phase
protein
support
content
serum
albumin
marker
inflamm
acut
phase
respons
start
local
reaction
site
injuri
character
activ
granulocyt
mononuclear
cell
turn
releas
acut
phase
cytokin
tumor
necrosi
factoralpha
interferon
act
via
specif
hepat
receptor
potent
induc
acut
phase
protein
synthesi
creactiv
protein
amyloida
simultan
inhibit
synthesi
albumin
activ
endotheli
cell
monocyt
macrophag
fibroblast
major
sourc
system
inflamm
via
posit
autocrin
feedback
loop
promot
prolifer
lung
fibroblast
hypoalbuminemia
may
thu
marker
ongo
inflamm
fibroblast
activ
patient
iip
togeth
may
explain
reduc
surviv
observ
hypoalbuminem
iip
patient
albuminmort
associ
seen
iip
patient
await
transplant
independ
la
score
use
priorit
patient
lung
transplant
futur
investig
requir
determin
whether
serum
albumin
measur
time
list
may
combin
la
improv
transplant
priorit
studi
sever
limit
need
acknowledg
first
effort
isol
effect
inflammationrel
hypoalbuminemia
adjust
variou
noninflammatori
caus
hypoalbuminemia
limit
covari
avail
optn
uno
databas
covari
may
imperfect
surrog
condit
instanc
although
use
bmi
correl
malnutrit
unabl
directli
assess
nutrit
intak
howev
given
high
bmi
lowest
serum
albumin
level
highli
unlik
clinic
malnourish
use
serum
creatinin
adjust
urinari
protein
loss
sinc
proteinuria
measur
similarli
corticosteroid
use
diabet
may
accur
character
factor
influenc
albumin
synthesi
endogen
cortisol
insulin
level
moreov
could
adjust
hepat
dysfunct
renal
liver
dysfunct
could
caus
hypoalbuminemia
studi
less
like
patient
solid
organ
diseas
usual
exclud
list
lung
transplant
also
limit
inabl
directli
assess
inflamm
via
measur
proinflammatori
cytokin
level
henc
studi
mechan
underli
associ
hypoalbuminemia
death
unclear
futur
investig
requir
determin
reason
low
serum
albumin
level
patient
iip
anoth
issu
diagnosi
ipf
standard
although
suspect
cohort
compos
mainli
ipf
patient
patient
cohort
rigor
document
ipf
standard
set
forth
atser
like
iip
therefor
comparison
result
cohort
welldefin
ipf
subject
made
caution
nonetheless
diagnost
heterogen
may
actual
increas
generaliz
result
patient
iip
await
lung
transplant
final
larg
group
patient
underw
transplant
censor
time
transplant
could
limit
generaliz
find
iip
mortal
applic
mortal
await
transplant
howev
lack
associ
albumin
probabl
transplant
cohort
indic
find
like
bias
censor
time
transplant
albuminmort
associ
document
may
applic
iip
mortal
consist
adjust
transplant
timedepend
covari
includ
posttranspl
surviv
low
serum
albumin
remain
strongli
independ
associ
high
mortal
iip
furthermor
sensit
analysi
assum
everyon
transplant
die
day
transplant
low
serum
albumin
also
remain
strongli
independ
associ
high
mortal
iip
weaken
expect
estim
underestim
real
relationship
albumin
mortal
repres
overcompens
transplant
censor
concern
summari
low
serum
albumin
strongli
independ
associ
poor
surviv
patient
iip
list
lung
transplant
investig
requir
clarifi
mechan
underli
associ
research
may
lead
intervent
may
lower
risk
mortal
among
iip
patient
work
support
part
grant
nation
institut
health
daz
jab
jat
ask
work
support
part
health
resourc
servic
administr
contract
david
zisman
receiv
research
grant
intermun
actelion
pharmaceut
multicent
studi
ipf
dr
zisman
schwarz
fund
nation
institut
health
ipf
clinic
research
network
includ
particip
pulmonari
hypertens
studi
sildenafil
dr
kawut
receiv
honoraria
actelion
encys
gilead
unit
therapeut
fund
research
intermun
bmi
bodi
mass
index
ci
confid
interv
fvc
forc
vital
capac
hr
hazard
ratio
iip
idiopath
interstiti
pneumonia
ipf
idiopath
pulmonari
fibrosi
la
lung
alloc
score
mpap
mean
pulmonari
pressur
determin
rightheart
catheter
optn
organ
procur
transplant
network
req
flow
rate
supplement
oxygen
requir
rest
rhc
rightheart
catheter
scr
serum
creatinin
star
standard
transplant
analysi
research
ucla
univers
california
lo
angel
uno
unit
network
organ
share
sixminut
walk
distanc
hazard
ratio
categori
serum
albumin
concentr
hr
hazard
ratio
model
adjust
demograph
age
gender
race
model
adjust
demograph
pulmonari
function
fvc
predict
flow
rate
supplement
oxygen
requir
rest
sixminut
walk
distanc
mean
pulmonari
arteri
pressur
determin
rightheart
catheter
model
adjust
demograph
pulmonari
function
potenti
confound
bodi
mass
index
corticosteroid
use
diabet
mellitu
serum
creatinin
eversmok
statu
